N.J. Couple Accuses AstraZeneca of Failing to Warn of Link Between Nexium, Kidney Disease

NEWARK, N.J. — A New Jersey couple have accused AstraZeneca Pharmaceuticals of failing to warn doctors and patients that its acid reflux drug Nexium can cause chronic kidney disease (CKD) and other serious injuries.

In an Aug. 18 complaint filed in the U.S. District Court for the District of New Jersey, the couple alleges that Nexium is defective and unreasonably dangerous because it was inadequately tested, contains hazardous design defects, and is accompanied by insufficient warnings as to CKD and other permanent injuries.

Bernita Garrison was prescribed Nexium on numerous occasions from January 2011 through September 2014, the lawsuit …